OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer?
Daniele Fanale, Lidia Rita Corsini, Chiara Brando, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 12
Daniele Fanale, Lidia Rita Corsini, Chiara Brando, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 12
Showing 12 citing articles:
Beyond the anti-PD-1/PD-L1 era: promising role of the BTLA/HVEM axis as a future target for cancer immunotherapy
Christian Sordo‐Bahamonde, Seila Lorenzo‐Herrero, Rocío Granda‐Díaz, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 44
Christian Sordo‐Bahamonde, Seila Lorenzo‐Herrero, Rocío Granda‐Díaz, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 44
BTLA biology in cancer: from bench discoveries to clinical potentials
Anna Andrzejczak, Lidia Karabon
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 19
Anna Andrzejczak, Lidia Karabon
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 19
Immune Checkpoint Inhibitors-Related Myocarditis: A Review of Reported Clinical Cases
Zotova La
Diagnostics (2023) Vol. 13, Iss. 7, pp. 1243-1243
Open Access | Times Cited: 33
Zotova La
Diagnostics (2023) Vol. 13, Iss. 7, pp. 1243-1243
Open Access | Times Cited: 33
Soluble TIM-3 as a biomarker of progression and therapeutic response in cancers and other of human diseases
Christian Bailly, Xavier Thuru, Laurence Goossens, et al.
Biochemical Pharmacology (2023) Vol. 209, pp. 115445-115445
Open Access | Times Cited: 21
Christian Bailly, Xavier Thuru, Laurence Goossens, et al.
Biochemical Pharmacology (2023) Vol. 209, pp. 115445-115445
Open Access | Times Cited: 21
A novel disulfidptosis-related immune checkpoint genes signature: forecasting the prognosis of hepatocellular carcinoma
Yuxin Chen, Wanying Xue, Yuting Zhang, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 14, pp. 12843-12854
Open Access | Times Cited: 11
Yuxin Chen, Wanying Xue, Yuting Zhang, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 14, pp. 12843-12854
Open Access | Times Cited: 11
Low plasma PD-L1 levels, early tumor onset and absence of peritoneal carcinomatosis improve prognosis of women with advanced high-grade serous ovarian cancer
Daniele Fanale, Chiara Brando, Lidia Rita Corsini, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 8
Daniele Fanale, Chiara Brando, Lidia Rita Corsini, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 8
Clinical relevance of exosome-derived microRNAs in Ovarian Cancer: Looking for new tumor biological fingerprints
Daniele Fanale, Lidia Rita Corsini, Marco Bono, et al.
Critical Reviews in Oncology/Hematology (2023) Vol. 193, pp. 104220-104220
Closed Access | Times Cited: 4
Daniele Fanale, Lidia Rita Corsini, Marco Bono, et al.
Critical Reviews in Oncology/Hematology (2023) Vol. 193, pp. 104220-104220
Closed Access | Times Cited: 4
Evolving Landscape of Detection and Targeting miRNA/Epigenetics for Therapeutic Strategies in Ovarian Cancer
Arpan Dey Bhowmik, Pallab Shaw, Mohan Shankar Gopinatha Pillai, et al.
Cancer Letters (2024) Vol. 611, pp. 217357-217357
Closed Access | Times Cited: 1
Arpan Dey Bhowmik, Pallab Shaw, Mohan Shankar Gopinatha Pillai, et al.
Cancer Letters (2024) Vol. 611, pp. 217357-217357
Closed Access | Times Cited: 1
Analysis of prognostic value of lactate metabolism-related genes in ovarian cancer based on bioinformatics
Jinrui Sun, Qinmei Feng, Yingying Xu, et al.
Journal of Ovarian Research (2024) Vol. 17, Iss. 1
Open Access
Jinrui Sun, Qinmei Feng, Yingying Xu, et al.
Journal of Ovarian Research (2024) Vol. 17, Iss. 1
Open Access
From immunomodulation to therapeutic prospects: Unveiling the biology of butyrophilins in cancer
Fatemeh Mehdikhani, Aysa Bahar, Marzieh Bashi, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 5
Closed Access
Fatemeh Mehdikhani, Aysa Bahar, Marzieh Bashi, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 5
Closed Access
Identification of Causal Risk Factors for Pan-Cancers: a Mendelian Randomization Study
Bowen Du, Fan Li, Chaopeng Tang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Bowen Du, Fan Li, Chaopeng Tang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Analysis of prognostic value of lactate metabolism-related genes in ovarian cancer based on bioinformatics
Jinrui Sun, Yingying Xu, Ping Liu, et al.
Research Square (Research Square) (2023)
Open Access
Jinrui Sun, Yingying Xu, Ping Liu, et al.
Research Square (Research Square) (2023)
Open Access
